Dry Eye Syndrome Market valued at approximately USD 5.2 billion in 2023 With CAGR of 4.21% by 2030

Comments · 12 Views

Dry Eye Syndrome Market valued at approximately USD 5.2 billion in 2023 With CAGR of 4.21% by 2030

Overview of Dry Eye Syndrome Market Size & Future Outlook

According to the latest report by MarkNtel Advisors, the Global Dry Eye Syndrome Market size is estimated to grow at a CAGR of around 4.21% from 2024-2030. This report is designed to enhance user understanding and support informed decision-making by thoroughly analyzing key market shifts, identifying gaps, exploring emerging opportunities, and assessing industry trends and competitive challenges. By combining both qualitative and quantitative data, it offers a comprehensive overview, highlighting growth prospects and providing valuable insights into competitors, helping both established companies and new entrants navigate the current market landscape.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

What are the key drivers influencing the growth of the Dry Eye Syndrome market?

This section provides a detailed analysis of the market drivers and factors is explored thoroughly below.

Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.

How is the Dry Eye Syndrome market segmented and what are the key factors within each segment?

The Dry Eye Syndrome market has been further segmented into distinct categories. Analyzing growth within these segments allows you to identify niche opportunities, develop targeted strategies, and understand the variations in your core application areas and target markets.

By Product

  • Artificial Tears- Market Size & Forecast 2019-2030, USD Million
  • Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
    • Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
    • Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
  • Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
    • Dissolvable-- Market Size & Forecast 2019-2030, USD Million
    • Removable-- Market Size & Forecast 2019-2030, USD Million
  • Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

By Disease Type

  • Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
  • Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

  • Offline- Market Size & Forecast 2019-2030, USD Million
    • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
    • Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
  • Online- Market Size & Forecast 2019-2030, USD Million

By Competition

  • Competition Characteristics
  • Market Share Analysis

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Who are the Key Market Players in the Dry Eye Syndrome industry?

The competitive landscape of the Dry Eye Syndrome market provides a detailed look at the key players in the industry. This includes an overview of each company, their financial performance, revenue generation, and market potential. It also covers their investments in R&D, new market initiatives, production facilities, and strengths and weaknesses. Additionally, the analysis looks at recent product launches, approvals, the range of products offered, their dominance in different applications, and the product life cycle. All of this information is specifically focused on how each company is positioning itself within the market.

Several key players are actively operating in the market, including

  • Mitotech Pharma
  • ReGen Tree
  • Santen Pharmaceutical
  • HanAll BioPharma
  • Sun Pharma
  • Novaliq
  • Sylentis
  • Alcon
  • Horus Pharma
  • Johnson & Johnson
  • Alderya Therapeutics
  • Visufarma
  • Allergan
  • Prestige Consumer Health
  • Others
  • Others.

Market Advancement by Leading Companies:

  • 2023: Novaliq & Bosch+Laumb announced the publication of pivotal phase 3 data of their ophthalmic drug NOVO3, which is developed to treat the signs & symptoms of Dry Eye Disease associated with meibomian gland dysfunction.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

Why Choose MarkNtel Advisors:

  • Focused Industry Expertise
  • Diverse Report Offerings
  • Personalized Research Solutions
  • Robust Research Methodology
  • In-depth Report Coverage
  • Tracking Technological Advancements
  • Comprehensive Value-Chain Analysis
  • Discovering Market Opportunities
  • Analyzing Growth Trajectories
  • Assured Quality Insights
  • Dedicated After-Sales Support
  • Trusted by Fortune 500 Companies

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Comments
ADVERTISE || APPLICATION || AFFILIATE



AS SEEN ON
AND OVER 250 NEWS SITES
Verified by SEOeStore